Clinical Trial

Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia

Name: Vivifi Device Safety Evaluation for the Treatment of Benign Prostatic Hyperplasia — clinical trial record (NCT07745621)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: BPH

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The study objective is to evaluate the safety and feasibility of the Vivifi device to treat symptomatic, benign prostatic hyperplasia (BPH).

Trial Details

NCT Number	NCT07745621
Lead Sponsor	Vivifi Medical Collaborators: RQM Plus
Conditions	Benign Prostatic Hyperplasia
Enrollment	20 participants
Start Date	2026-09
Primary Completion	2027-02 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-08-04